Loading...

AJANTPHARM Ajanta Pharma Ltd Investments Divestments Announcement

jnt

JNTP

Ajanta Pharma Ltd

(AJANTPHARM)

2026 Announcement

SEBI SAST Disclosure

Regulatory Compliance

Earnings Call Transcript

Newspaper Publication

Earnings call recording

Auditor re-appointments

ESOP grant and cancellation

Earnings Release

Audited results

Inspection findings

Earnings Conference Call

Regulatory compliance

Regulatory Disclosure

Regulatory compliance

Pledge creation and release

Regulatory disclosure

Trading Window Closure

SEBI SAST disclosure

Analyst/Institutional Meeting

SEBI SAST Disclosure

SEBI SAST Disclosure

Pledge creation

Pledge Release under SAST

Earnings Call Transcript

Analyst/Institutional Meetings

Reg 47 Disclosure

Audio recording

Stock-based incentives

Q3 FY2026 earnings release

Unaudited results (Q3 & 9M)

Wholly Owned Subsidiary

Earnings Conference Call

Regulatory Compliance

SEBI SAST disclosure

Pledge Creation

Trading window closure

In-licensing agreement

Regulatory disclosure

Promoter share pledge

Promoter pledge disclosure

SEBI SAST disclosure

Earnings Call Transcript

Financial Results Publication

Earnings Call Audio

Office Address Change

Dividend Record Date

Dividend Announcement

Financial Results

Q2 Earnings Report

Interim Dividend Announcement

Dividend Consideration

Board Meeting Update

Earnings Call Notice

Sustainability Report Submi...

Compliance Certificate

Dividend Claims Notice

Investor Conference

Income Tax Search

Earnings Call Summary

Financial Results Published

Earnings Call Audio

Earnings Call Scheduled

Compliance Certificate

AGM E-Voting Notice

AGM Announcement

Compliance Report

Earnings Call Transcript

Financial Results Published

Earnings Call Recording

Cancellation of ESOPs

Management Changes

Director Change

Earnings Conference Call

Capacity Expansion

Investor Conference

Investor Conference Partici...

Stock Appreciation Rights

Earnings Call Transcript

Financial Results Publication

Earnings Call Audio

Stock Options Canceled

Earnings Call Scheduled

SEBI Compliance Certificate

Earnings Call Transcript

Financial Results Released

Earnings Call Update

Dividend Announcement

Earnings Call Announcement

SEBI Compliance Certificate

Investor Conference

Investor Conference

Earnings Call Transcript

Financial Results Published

Earnings call recording upl...

Equity Allotment

Director Cessation

Earnings Conference Call

Certificate Submission

Buy-back completion

Buyback of Equity Shares

Publication Notice

Compliance Report Submission

Investor Conference

Earnings Call Transcript

Buyback of Shares

Buyback Approval

Cost Auditor Change

Financial Results Publication

Earnings Call Recording Upl...

Appointments and Auditor Ch...

Appointment of Directors an...

Equity Shares Allotted

Earnings Call Scheduled

Regulation Compliance

Compliance Certificate

Certificate Submission

Transcript Uploaded

Investor Conferences

Financial Results

Earnings Call Recording Upload

Cancellation of ESOPs

Earnings Conference Call

Correction of Error

Earnings Conference Call

Unclaimed Dividends

Certificate Submission

Schedule of Meetings

Earnings Call Transcript

Financial Results

Earnings Call Recording

Earnings Conference Call

Certificate Submission

Clarification Response

Newspaper Publication

Analyst/Institutional Inves...

Earnings Releases

Merger of Equals

Annual General Meeting

US FDA Inspection

Corporate Governance

Meeting Announcement

Management Changes

Financial Results Publication

Related Party Transactions ...

Equity Offerings

External Links:

Data:

Ajanta Pharma approves vesting of 4,300 cash‑settled SARs and cancels 800 ESOPs under SBIP 2019; cash settlement based on Feb 2, 2026 closing price; no equity issuance or dilution expected.

AI Assistant

Ajanta Pharma Ltd

2026

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.